Dolutegravir and Cardiovascular Events: Reassurance With Remaining Uncertainty

Clinical Infectious Diseases 2026

View at publisher

Authors: E Segarra Martínez

DOI: 10.1093/cid/ciag279

Cited by: 1

References: 5

Fields of Study & Subjects

HIV-related health complications and treatments HIV/AIDS drug development and treatment Lipoproteins and Cardiovascular Health

References 5